Robert Pordy

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

Robert Dufour, D. Gaudet, E. Stein, 2012, The Lancet.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

J Wouter Jukema, Deepak L. Bhatt, Deepak L Bhatt, 2018, The New England journal of medicine.